{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Keep Beta Blocking and Carry On
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
Method of Participation in the Learning Process/Evaluation Method Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form. Getting the Most out of the Activity As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed. While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.Learning Objectives
After completing this continuing education activity you will be able to:
- Describe how to follow patients with advanced liver disease.
- Define the criteria for clinically significant portal hypertension (CSPH).
- Outline methods to decrease the risk of complications from CSPH.
Disclosures
Atoosa Rabiee provides consultation and educational seminars for GORE. The remaining author, faculty, and staff have no relevant financial relationships with any ineligible organizations regarding this educational activity.
Lippincott CME Institute has identified and mitigated all relevant financial relationships regarding this educational activity.
Price:
$30.00
Credits:
- ACCME 1.0 CME
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Physician
Test Code: CLD0124A
Published: January 2024
Expires: 1/31/2026
Sources:
Clinical Liver Disease
Required Passing Score: 3/4 (75%)
Categories:
Hepatology
Specialties:
Hepatology
Topics:
Beta-blockers